阿尔茨海默病早期生物学诊断标志物研究进展
被引量:7
Recent advance in early diagnostic biomarkers of Alzheimer's disease
摘要
阿尔茨海默病(Alzheimer’Sdisease,AD)是老年性痴呆最常见的类型之一,随着年龄的增长,其患病率不断增高^[1]。虽然病理学研究早已证实,AD患者脑内的病理生理变化始于中年时期.但目前的临床现状是大部分患者在老年期或老年前期因为出现相关的认知功能障碍症状才被发现,
出处
《中华神经医学杂志》
CAS
CSCD
北大核心
2013年第3期314-317,共4页
Chinese Journal of Neuromedicine
参考文献28
-
1Blennow K, de Leon M J, Zetterberg H. Alzheimer's disease [J]. Lancet, 2006, 368(9533): 387-403.
-
2Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer' s disease: progress and problems on the road to therapeutics [J]. Science, 2002, 297(5580): 353-356.
-
3Thai IA, Kantarci K, Reiman EM, et al. The role of biomarkers in clinical trials for Alzheimer disease [J]. Alzheimer Dis Assoc Disord, 2006, 20(1): 6-15.
-
4Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide [J]. Nat Rev Mol Cell Biol, 2007, 8(2): 101-112.
-
5Shankar GM, Li S, Mehta TH, et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory [J]. Nat Med, 2008, 14(8): 837-842.
-
6Georganopoulou DG, Chang L, Nam JM, et al. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease [J]. Proc Natl Acad Sci U S A, 2005, 102 (7): 2273-2276.
-
7Fukumoto H, Tokuda T, Kasai T, et al. High-molecular-weight β-amyloid oligomers are elevated in eerebrospinal fluid of Alzheimer patients [J]. FASEB J, 2010, 24(8): 2716-2726.
-
8Santos AN, Simm A, HolthoffV, et al. A method for the detection of amyloid-β1-40, amyloid-β1-42 and amyloid-β oligomers in blood using magnetic beads in combination with flow cytometry and its application in the diagnostics of Alzheimer's disease [J]. J Alzheimers Dis, 2008, 14(2): 127-131.
-
9Enghmd H, Gunnarsson MD, Brundin RM, et al. Oligomerization partially explains the lowering of AI342 in alzheimer's disease cerebrospinal fluid [J]. Neurodegener Dis, 2009, 6(4): 139-147.
-
10Craig-Schapiro R, Fagan AM, Holtzman DM. Biomarkers of Alzheimer' s disease [J]. Neurobiology of Disease, 2009, 35 (2): 128-140.
同被引文献67
-
1Weuve J,Hebert LE,Scherr PA,et al.Deaths in the United States among persons with Alzheimer's disease (2010-2050)[J].Alzheimers Dement,2014,10(2):40-46.
-
2Li L,Yang R,Sun K,et al.Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca2+ influx of NMDA receptors[J].Int J Neuropsychopharmacol,2012,15(4):497-507.
-
3Youmans KL,Tai LM,Nwabuisi-Heath E,et al.APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease[J].J Biol Chem,2012,287(50):41774-41786.
-
4Castellano JM,Kim J,Stewart FR,et al.Human apoE isoforms differentially regulate brain amyloid-β peptide clearance[J].Sci Transl Med,2011,3(89):89ra57.
-
5LaClair KD,Manaye KF,Lee DL,et al.Treatment with bexarotene,compound that increases apolipoprotein-E,provides no cognitive benefit in mutantAPP/PS1 mice[J].Mol Neurodegener,2013,8:18.
-
6Cramer PE,Cirrito JR,Wesson DW,et al.ApoE-directed therapeutics rapidly clear β3-amyloid and reverse deficits in AD mouse models[J].Science,2012,335(6075):1503-1506.
-
7Liu CC,Kanekiyo T,Xu H,et al.Apolipoprotein E and Alzheimer disease:risk,mechanisms and therapy[J].Nat Rev Neurol,2013,9 (2):106-118.
-
8Chong ZZ,Shang YC,Wang S,et al.Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin[J].Prog Neurobiol,2012,99(2):128-148.
-
9Rothman SM,Griffioen KJ,Wan R,et al.Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health[J].Ann N Y Acad Sci,2012,1264(1):49-63.
-
10Sokolowska-Wojdylo M,Florek A,Zaucha JM,et al.Polish lymphoma research group experience with bexarotene in the treatment of cutaneous T-Cell lymphoma[J].Am J Ther,2014,[Epub ahead of print].
引证文献7
-
1陆卉,张涛.蓓萨罗丁对AD小鼠空间认知、学习记忆损伤及海马神经再生的影响[J].中华神经医学杂志,2014,13(5):478-483. 被引量:2
-
2张媚,熊莉君,肖明月.轻度认知功能损害患者血清磷酸化tau蛋白水平变化及其临床意义[J].中国现代医学杂志,2014,24(11):79-81. 被引量:10
-
3周泽芬,王凌晞,杜烨鸿,刘刚,徐明亮,姚秋会,张婷,汪克建,贺桂琼.APP/PS1双转基因小鼠视网膜内β-淀粉样蛋白及星形胶质细胞的变化[J].中华神经医学杂志,2014,13(8):768-771. 被引量:3
-
4黄琼.老年阿尔茨海默病神经内科诊断及治疗研究[J].当代医学,2016,22(5):35-36. 被引量:6
-
5李瑜霞,王晓妮,孙宇,夏明睿,李永秋,李一凡,李坤成,韩璎.轻度认知障碍患者痴呆转化预测的结构MRI纵向研究[J].中华神经医学杂志,2016,15(4):384-390. 被引量:10
-
6周丽华,徐武华.Tau蛋白相关标志物对阿尔茨海默病的诊断价值[J].实用老年医学,2017,31(3):285-287. 被引量:5
-
7童宁.阿尔茨海默病患者血清CD33水平及其临床意义[J].慢性病学杂志,2018,18(6):694-697.
二级引证文献36
-
1王珊珊,郑加平,董丽华,隋世华,江秀丽,路伟,刘致利.轻度认知功能障碍患者认知损害及与血清p-tau蛋白的相关性研究[J].中华临床医师杂志(电子版),2015,9(17):52-55. 被引量:6
-
2何本进,梁庆华,胡才友,孙亮,朱小泉,原惠萍,杨帆,李星慧,秦娇琴,贾春媛,韩晶,杜建财,张翻弟,杨泽.阿尔茨海默病的临床检测指标现状[J].中国老年保健医学,2015,13(5):35-38. 被引量:3
-
3王雪,刚宝芝.临床前期主观认知下降与轻度认知功能障碍[J].现代医学,2016,44(6):903-906. 被引量:4
-
4陈睿,余燕玲,江婷,徐世芬,黎程.电针对抑郁症大鼠模型行为学及海马ERK/CREB信号通路表达的影响[J].中华神经医学杂志,2016,15(9):913-917. 被引量:6
-
5王兴盛,何燕,刘光明.不同肾功能损伤患者认知功能差异分析[J].中国现代医学杂志,2016,26(23):132-135. 被引量:6
-
6陈以丽.痴呆与轻度认知障碍的流行病学、发病机制和诊治分析[J].临床合理用药杂志,2017,10(1):172-173. 被引量:25
-
7董志章,李娟,孙雪荣,葛坚.高强度光照损伤致TgAPPswePS1转基因鼠脉络膜新生血管形成[J].眼科新进展,2017,37(2):101-105. 被引量:3
-
8吴有林,刘芳.轻度认知功能障碍转化为阿尔茨海默病痴呆的危险因素研究进展[J].癫痫与神经电生理学杂志,2017,26(3):188-192. 被引量:1
-
9王东春,李晓丽,张坤,秦丽娟.A2AR活化在脑创伤后tau蛋白过度磷酸化中的作用与机制研究[J].中国生化药物杂志,2017,37(7):25-28. 被引量:2
-
10申潇竹,董燕,汪玲玲,龚晨,高鹏翔,包勤文,王新,田昌荣.广泛性脑萎缩者血浆tau蛋白、磷酸化tau蛋白水平与认知功能的关系[J].中国神经精神疾病杂志,2017,43(10):608-611. 被引量:2
-
1吴杰贤,余周伟,冯慧宇,黎杰.糖尿病合并脑梗死患者认知功能障碍的影响因素[J].广东医学,2014,35(22):3502-3505. 被引量:16
-
2金丽华,李勇.卒中后抑郁的临床现状[J].中国医药,2008,3(6):379-381. 被引量:11
-
3阎柏令.血塞通治疗肝纤维化的临床现状[J].中国民康医学,2009,21(24):3193-3193.
-
4宋水江,戴加勇,汤永国.脑出血相关治疗指南与临床现状[J].中国实用内科杂志,2013,33(8):612-614. 被引量:28
-
5范泓洋,沈恺妮.大规模研究发现中年时期体重过低与痴呆相关[J].英国医学杂志中文版,2015,0(7):377-377.
-
6陈晨,王晓平.对偏头痛临床现状的一些思考[J].世界临床药物,2013,34(7):385-388. 被引量:9
-
7中年酗酒易患老年痴呆[J].养生大世界,2006(03A):63-63.
-
8董玺,韩学努.早期康复治疗脑卒中偏瘫的临床现状[J].中国社区医师(医学专业),2006,8(17):4-4.
-
9任兆瑞.中国人亨廷顿舞蹈病的分子诊断研究[J].医学研究杂志,1999,33(9):15-15.
-
10张泽明,张凌.高血压局限性脑出血的CT动态观察——附36例CT分析[J].攀枝花医药,1996,18(1):28-28.